XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of fair values of stock options granted, estimated using Black-Scholes option valuation model assumptions
We estimated the fair value of stock options awarded during the six months ended June 30, 2017 and 2018 using the Black-Scholes option valuation model. The fair values of stock options granted for the periods were estimated using the following assumptions: 
 
Stock Option Grants Awarded During the Six Months Ended June 30, 2017
 
Stock Option Grants Awarded During the Six Months Ended June 30, 2018
Stock Price
$4.36 to $4.68
 
$4.12 to $5.96
Dividend Yield
0.00%
 
0.00%
Expected Volatility
60%
 
70%
Risk-free interest rate
1.98% - 2.14%
 
2.50% - 2.89%
Expected Life
7 years
 
7 years
Summary of stock option activity
The following is a summary of our stock option activity during the six months ended June 30, 2018: 
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Grant Date
Fair Value
 
Weighted
Average
Remaining
Life In
Years
Outstanding, January 1, 2018
1,082,490

 
$
4.87

 
$
3.00

 
8.38
Granted
117,500

 
4.93

 
3.34

 
9.00
Exercised
(4,692
)
 
2.91

 
1.75

 
—
Canceled / Forfeited
(65,645
)
 
4.72

 
2.89

 
—
Outstanding, June 30, 2018
1,129,653

 
$
4.89

 
$
3.05

 
8.02

 
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Grant Date
Fair Value
 
Weighted
Average
Remaining
Life In
Years
Exercisable, January 1, 2018
704,303

 
$
5.08

 
$
3.17

 
8.15
Vested
74,002

 
4.76

 
2.89

 
7.69
Exercised
(4,692
)
 
2.91

 
1.75

 
—
Canceled / Forfeited
(16,432
)
 
4.69

 
2.80

 
—
Exercisable, June 30, 2018
757,181

 
$
5.07

 
$
3.16

 
7.66
Schedule of information related to stock options outstanding and exercisable
The following table presents information related to stock options outstanding and exercisable at June 30, 2018: 
Options Outstanding
 
Options Exercisable
Exercise
Price
 
Outstanding
Number of
Options
 
Weighted
Average
Remaining
Life In
Years
 
Exercisable
Number
of Options
$1.93 – $2.00
 
146,183

 
7.60
 
81,009

$3.83 – $4.75
 
556,045

 
8.90
 
355,058

$5.01 – $6.00
 
267,125

 
6.21
 
202,358

$6.18 – $7.20
 
70,000

 
6.34
 
49,697

$7.54 – $7.80
 
67,800

 
6.54
 
50,299

$8.06 – $12.98
 
22,500

 
6.55
 
18,760

 
 
1,129,653

 
7.66
 
757,181

Schedule of restricted stock unit activity
A summary of restricted stock unit activity for the six months ended June 30, 2018 is as follows: 
 
Number of
Restricted Share
Units
 
Weighted-
Average
Grant-Date Fair
Value Per Share
Outstanding at January 1, 2018
1,476,858

 
$
4.96

Granted
1,171,304

 
4.76

Vested
(478,816
)
 
5.01

Forfeited
(6,799
)
 
4.98

Outstanding at June 30, 2018
2,162,547

 
$
4.84

Schedule of stock-based compensation
Total equity-based compensation costs recorded in the condensed consolidated statements of operations is allocated as follows: 
 
 
Three Months Ended June 30, 2017
 
Three Months Ended June 30, 2018
 
Six Months Ended June 30, 2017
 
Six Months Ended June 30, 2018
Research and development
 
 
 
 
 
 
 
 
Employees
 
$
309,000

 
$
767,000

 
$
535,000

 
$
1,303,000

Non-employees
 
15,000

 
49,000

 
41,000

 
44,000

Total research and development
 
324,000

 
816,000

 
576,000

 
1,347,000

 
 
 
 
 
 
 
 
 
General and administrative
 
 
 
 
 
 
 
 
Employees and directors
 
317,000

 
727,000

 
684,000

 
1,134,000

Non-employees
 
24,000

 
84,000

 
98,000

 
109,000

Total general and administrative
 
341,000

 
811,000

 
782,000

 
1,243,000

 
 
 
 
 
 
 
 
 
Total equity-based compensation
 
$
665,000

 
$
1,627,000

 
$
1,358,000

 
$
2,590,000